CoChat

A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Iron maldistribution has been implicated in the etiology of many diseases including the anemia of inflammation (AI), atherosclerosis, diabetes, and neurodegenerative disorders. Iron metabolism is controlled by hepcidin, a 25-amino-acid peptide. Hepcidin is induced by inflammation and causes iron to be sequestered within cells of the reticuloendothelial system, suppressing erythropoiesis and blunting the activity of erythropoiesis stimulating agents (ESAs). For this reason, neutralization of hepcidin has been proposed as a therapeutic treatment of AI. The aim of the current work was to generate fully human anti-hepcidin antibodies (Abs) as a potential human therapeutic for the treatment of AI and other iron maldistribution disorders. An enzyme-linked immunosorbent assay was established using these Abs to identify patients likely to benefit from either ESAs or anti-hepcidin agents. Using human hepcidin knock-in mice, the mechanism of action of the Abs was shown to be due to an increase in available serum iron leading to enhanced red cell hemoglobinization. One of the Abs, 12B9m, was validated in a mouse model of AI and demonstrated to modulate serum iron in cynomolgus monkeys. The 12B9m Ab was deemed to be an appropriate candidate for use as a potential therapeutic to treat AI in patients with kidney disease or cancer.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2013-06-505792

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Steensma, 2011, The relationship between serum hepcidin levels and clinical outcomes in patients with chemotherapy-associated anemia treated in a controlled trial [abstract]., J Clin Oncol, 29

Cited by

See all 120

Metadata

Authors
Cooke, K. S., Hinkle, B., Salimi-Moosavi, H., Foltz, I., King, C., Rathanaswami, P., Winters, A., Steavenson, S., Begley, C. G., Molineux, G., & Sasu, B. J.
Affiliations
  • Department of Oncology,
  • Department of Comparative Biology and Safety Science,
  • Department of Pharmacokinetics and Drug Metabolism, and
  • Amgen (United States) (US)
Venue
Blood
Published
2013-10-24
Volume
122
Issue
17
Pages
3054-3061
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2079355070
Cited by
113
References
29
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 10 · 2020: 14 · 2019: 6 · 2018: 13 · 2017: 17 · 2016: 14 · 2015: 9 · 2014: 14 · 2013: 2
FWCI
9.32
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
Amgen
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
Keywords
hepcidin, iron metabolism, anemia of chronic disease, erythropoiesis-stimulating agents, serum iron, erythropoiesis, Macaca fascicularis, humanized monoclonal antibody, kidney disease, cancer
MeSH terms
Animals, Disease Models, Animal, Drug Evaluation, Preclinical, Enzyme-Linked Immunosorbent Assay, Erythrocytes, Erythropoiesis, Female, Hematinics, Hemoglobins, Humans, Inflammation, Iron, Macaca fascicularis, Male, Anemia, Iron-Deficiency, Mice, Antibodies, Neutralizing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates. https://app.cochat.ai/papers/10.1182/blood-2013-06-505792
The paper
Cooke, K. S., Hinkle, B., Salimi-Moosavi, H., Foltz, I., King, C., Rathanaswami, P., Winters, A., Steavenson, S., Begley, C. G., Molineux, G., & Sasu, B. J. (2013). A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates. Blood. https://doi.org/10.1182/blood-2013-06-505792

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.